Hospitals & Clinics
-
Opportunity India Desk May 08, 2018 - 1 min readDrug firm Suven Life Sciences has confirmed that its Pashamylaram facility near Hyderabad has undergone successful inspection by the US health regulator. The facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA), Suven Life Sciences said in a filing to BSE.
-
Opportunity India Desk May 07, 2018 - 2 min readTata Trusts has announced to set up and manage a state-of-the-art cancer treatment and research hospital in Bhubaneswar. Odisha government on Sunday signed a memorandum of understanding (MoU) with Tata Trusts for the same. The state government will provide 25-acre land free of cost for the Tata’s Cancer Care Centre, which ...
-
Opportunity India Desk May 05, 2018 - 1 min readDrug firm Zydus Cadila has received approval from the US health regulator to sell its anesthetic injection, Succinylcholine Chloride in the American market. The medication is used as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. The ...
-
Opportunity India Desk Apr 26, 2018 - 1 min readRenuka Ramnath, founder of private equity firm Multiples Alternate Asset Management, has resigned from the advisory committee constituted for the evaluation binding bids for its sale by the board of Fortis Healthcare Ltd. An advisory panel set up by the Fortis board was scheduled to meet on Wednesday to evaluate multiple ...
-
Opportunity India Desk Apr 16, 2018 - 1 min readThe Bengaluru-based healthcare startup PregBuddy has raised an undisclosed amount in a seed round led by Indian Angel Network (IAN). in a statement, the startup revealed the names of investors who participated in the round included Google India managing director and IAN member Rajan Anandan; Madhusudhan Kannan, chief business officer of ...
-
Opportunity India Desk Apr 13, 2018 - 3 min readIndia’s second largest private hospital chain, Fortis Healthcare Ltd. has received a joint investment proposal from Hero Enterprise Investment Office and the Burman Family Office, intensifying a race to gain control of healthcare major. The two Indian business families have made a binding offer to invest a total of 12.5 billion ...
-
Opportunity India Desk Apr 11, 2018 - 1 min readAlembic Pharma has received approval from the US health regulator its Acyclovir a, used for the treatment of genital herpes. The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 percent, Alembic Pharmaceuticals said in a BSE filing. The approved ...
-
Opportunity India Desk Apr 06, 2018 - 1 min readDrug firm Lupin has confirmed to have received an Establishment Inspection Report (EIR) from the US health regulator for its Pithampur, Unit 1 manufacturing facility in Madhya Pradesh. The inspection was conducted in July 2017, it said in a BSE filing. USFDA gives EIR on the closure of inspection ...
-
Opportunity India Desk Apr 05, 2018 - 1 min readOne of the largest Pharmaceutical companies of US, Glenmark Pharmaceuticals is recalling over one lakh bottles of anti-inflammatory Indomethacin capsules from the US market due to incorrect instructions on the labelling, latest Enforcement report of the US regulator has said. The US-based pharmacy company is recalling 109,080 bottles of Indomethacin capsules ...
-
Opportunity India Desk Apr 04, 2018 - 2 min readThe US Trade Representative (USTR) is considering to revoke special tariff provided to India if it continues with its pricing policy on medical devices manufactured by American companies, two people aware of the development said. The USTR representatives, who are expected to visit India on April 9, will be meeting Indian ...